𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial

✍ Scribed by L. Biancone; C. Tosti; A. Geremia; D. Fina; C. Petruzziello; S. Emerenziani; F. Pallone

Book ID
108603531
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
93 KB
Volume
19
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Preliminary observations of oral nicotin
Preliminary observations of oral nicotine therapy for inflammatory bowel disease: An open-label phase I-II study of tolerance
✍ John Robert Ingram; John Rhodes; Brian K Evans; Dr. Gareth A. O. Thomas πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 200 KB

## Background: Transdermal nicotine provides benefit in active ulcerative colitis but is often associated with adverse events (aes). an oral formulation has been developed to minimize aes. this study was undertaken to make initial observations on the safety and tolerance of oral nicotine therapy in